DENTSPLY SIRONA Reports 4.9% Decline in Q2 2025 Net Sales, $45 Million Net Loss

DENTSPLY SIRONA Inc. reported a decline in financial performance for the second quarter of 2025, with net sales of $936 million, down 4.9% from $984 million in the same period last year. For the first half of 2025, net sales totaled $1.815 billion, a decrease of 6.3% compared to $1.937 billion in the first half of 2024. The company experienced a net loss attributable to DENTSPLY SIRONA of $45 million, or $(0.22) per share, for the second quarter, compared to a loss of $4 million, or $(0.02) per share, in the prior year. The six-month net loss was $25 million, compared to a profit of $14 million in the same period last year.

The decline in revenue was attributed to lower volumes in the Orthodontic and Implant Solutions segment, particularly due to the suspension of Byte sales, as well as decreased sales of CAD/CAM, imaging, and implant products. However, the Essential Dental Solutions segment saw growth, which partially offset the overall decline. The company also recorded significant impairment charges, including a $156 million goodwill impairment for the Implant & Prosthetic Solutions reporting unit and $79 million in intangible asset impairments, primarily due to competitive pressures and tariff impacts.

Operationally, DENTSPLY SIRONA has been undergoing restructuring initiatives aimed at improving efficiency and reducing costs. The company has implemented a 2024 restructuring plan, which anticipates a workforce reduction of 2% to 4% and aims to achieve annual cost savings of $80 million to $100 million by the end of 2025. As of June 30, 2025, the company incurred $30 million in restructuring charges related to this plan. The previous 2023 restructuring plan, which targeted $200 million in annual savings, has been largely met, although benefits have been offset by investments in sales personnel and a new global ERP system.

Geographically, the company reported a significant decline in sales in the United States, which fell 18.3% to $293 million in the second quarter, while European sales increased by 4.3% to $404 million. The Rest of World segment remained stable, with a slight increase in sales. The company continues to face challenges from macroeconomic conditions, including inflation and geopolitical tensions, which have affected consumer confidence and spending in the dental market.

Looking ahead, DENTSPLY SIRONA anticipates ongoing challenges due to economic uncertainties and competitive pressures. The company is focused on strategic procurement initiatives, cost-containment measures, and optimizing its customer management to navigate these conditions. The management remains committed to maintaining a disciplined approach to research and development, with expectations to invest at least 4% of annual net sales in this area.